Andrew Spaventa - 02 Dec 2021 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role: Chief Executive Officer, Director
Signature: /s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 06 Dec 2021, 17:40:01 UTC
Previous filing: 01 Jun 2021
Next filing: 11 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OMIC	Common Stock	Other		-715,884	-81%		173,144	02 Dec 2021	By Axon Holdings, LLC	F1, F2
holding	OMIC	Common Stock						4,613,571	02 Dec 2021	By The Andrew K. Spaventa Living Trust dated April 9, 2014

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were distributed on a pro rata basis by Axon Holdings, LLC.
F2	The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC. and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

Content

The shares were distributed on a pro rata basis by Axon Holdings, LLC.

The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC. and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.